共 117 条
- [3] [Anonymous], ONCOGENE
- [4] Anti-CD73 immunotherapy: A viable way to reprogram the tumor microenvironment [J]. ONCOIMMUNOLOGY, 2016, 5 (09):
- [6] CD39 and CD73 in immunity and inflammation [J]. TRENDS IN MOLECULAR MEDICINE, 2013, 19 (06) : 355 - 367
- [8] Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling [J]. SCIENTIFIC REPORTS, 2016, 6